association

Full identifier: http://purl.org/np/RADvWzU7FMF_ocwnz0qHhWBN6Dm6Y697VmKl-wh-w6uyU#association

Assigned to 1 class:

Minted in Nanopublication

 RADvWzU7FM comment approve/disapprove edit as derived nanopublication create new with same template

This is the identifier for this whole nanopublication. http://purl.org/np/RADvWzU7FM... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-06-12T16:50:20.448+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RADvWzU7FM... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAManV5GZI... RAManV5GZI .
This is the identifier for this whole nanopublication. http://purl.org/np/RADvWzU7FM... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RADvWzU7FM... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T14:50:20.448Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
levothyroxine sodium for injection is indicated for the treatment of myxedema coma important limitations of use the relative bioavailability between levothyroxine sodium for injection and oral levothyroxine products has not been established caution should be used when switching patients from oral levothyroxine products to levothyroxine sodium for injection as accurate dosing conversion has not been studied levothyroxine sodium is an l thyroxine product levothyroxine t 4 1 important limitations of use the relative bioavailability of this drug has not been established use caution when converting patients from oral to intravenous levothyroxine 1
Leoni Bücken
2021-06-12T14:50:20.448Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T14:50:20.448Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T14:50:20.448Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T14:50:20.448Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T14:50:20.448Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T14:50:20.448Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T14:50:20.448Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)